AGENUS INC — Director's Dealing 2019

Dec 23, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2018-04-06

Reporting Person: ARMEN GARO H (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-06	Common Stock	J	140974	$4.82	Disposed	1221433	Direct
2018-09-27	Common Stock	J	300000	$2.16	Acquired	1521433	Direct
2018-09-27	Common Stock	J	225000	$2.16	Disposed	1296433	Direct
2019-12-17	Common Stock	J	66000	$3.88	Disposed	1230433	Direct
2019-12-19	Common Stock	J	195358	$3.77	Disposed	1035075	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	229046	Indirect

Footnotes

F1: Represents shares donated to a charitable organization.

F2: Represents required distribution from the Garo Armen 2017 2 Year AG GRAT.

F3: Represents deposit of Agenus Inc. common stock into the Garo Armen 2018 2 Year AG GRAT.

F4: Dr. Armen is trustee and has investment authority for the Garo Armen 2018 2 Year AG GRAT holder of 225,000 shares of Agenus Inc. common stock. Dr. Armen is Chairman of the Board of Managers and a member of Antigenics LLC ("Antigenics") which as of the date of this reports owns 4,046 shares of Agenus Inc. common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Antigenics and disclaims beneficial ownership to the extent of his pecuniary interest therein.